[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371908-105":59,"doc-detail-371908-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","innovative-se-flutamide-derivatives-enhanced-activity-toward-androgen-receptor-ar-dependent-and-independent-prostate-cancer-cells","Innovative Se-Flutamide Derivatives: Enhanced Activity Toward Androgen Receptor (AR)-Dependent and -Independent Prostate Cancer Cells","","Sixteen novel selenoderivatives of flutamide were developed to target androgen receptor (AR)–dependent prostate cancer. The Se derivatives showed promising activity against the NCI-60 human cancer cell line panel, including two AR-independent prostate cancer lines (DU-145 and PC-3). In contrast to flutamide, compounds a2, a5, and b4 strongly inhibited AR-dependent LNCaP cell proliferation. For a5, regulated cell death was analyzed using cell death inhibitors, showing apoptosis via intrinsic and extrinsic pathways without reactive oxygen species (ROS) generation, alongside G0/G1 cell cycle arrest.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/innovative-se-flutamide-derivatives-enhanced-activity-toward-androgen-receptor-ar-dependent-and-independent-prostate-cancer-cells/371908/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/innovative-se-flutamide-derivatives-enhanced-activity-toward-androgen-receptor-ar-dependent-and-independent-prostate-cancer-cells/371908.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was developed in this study?","Question",{"text":112,"@type":113},"The study developed sixteen novel Se-derivatives of flutamide designed to enhance activity against AR-dependent and AR-independent prostate cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the Se-flutamide derivatives perform against cancer cell models?",{"text":117,"@type":113},"All Se derivatives showed promising activity across the NCI-60 panel, including AR-independent lines DU-145 and PC-3, while several compounds exhibited strong antiproliferative effects against AR-dependent LNCaP cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism of cell death did compound a5 trigger in LNCaP cells?",{"text":121,"@type":113},"Compound a5 promoted apoptosis by activating both intrinsic and extrinsic apoptotic pathways and did so without generating reactive oxygen species (ROS), also inducing G0/G1 cell cycle arrest.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371908,1790904208,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Archiv der Pharmazie   \n FULL PAPER   \nInnovative Se‐Flutamide Derivatives: Enhanced  \nActivity Toward Androgen Receptor (AR)‐Dependent and ‐Independent Prostate Cancer Cells  \nCristina Morán‐Serradilla1 | Carmen Sanmartín1  | Asif Raza2 | Ignacio Encío3 | Daniel Plano1  | Arun K. Sharma2 1Department of Pharmaceutical Sciences, University of Navarra, Irunlarrea, Spain | 2Department of Molecular and Precision Medicine, Penn State Cancer Institute, Penn State College of Medicine, Hershey, USA | 3Department of Health Sciences, Public University of Navarra, Pamplona, Spain Correspondence: Daniel Plano ([dplano@unav.es](dplano@unav.es))  \nReceived: 2 May 2025 | Revised: 31 August 2025 | Accepted: 23 September 2025  \nFunding: The research reported here was partially supported by National Institutes of Health instrumentation grants: 1S10OD028589‐01 and 1S10RR023439‐ 01 for the X‐ray equipment in the X‐ray core facility at the Pennsylvania State University.  \nKeywords: flutamide | prostate cancer | selenium  \nABSTRACT  \nSixteen novel selenoderivatives of flutamide, which is used for treating androgen receptor (AR)‐dependent prostate cancer, were developed. All the Se derivatives displayed promising activity against the NCI‐60 human cancer cell line panel, which also includes two AR‐independent prostate cancer cell lines, DU‐145 and PC‐3 . Conversely to flutamide, compounds a2, a5, and b4 exhibited a potent antiproliferative effect toward AR‐dependent LNCaP cells. Several cell death inhibitors were used to determine the underlying regulated cell death processes of a5. Regarding its mechanism of action in these cells, this compound promoted apoptosis by activating both intrinsic and extrinsic apoptotic pathways, without generating reactive oxygen species (ROS) . Besides, it induced the G0/G1 cell cycle arrest. Altogether, it could be concluded that this Se‐flutamide analog could be a feasible and promising candidate for further development for the treatment of both AR‐dependent and ‐independent prostate cancers.  \n1 | Introduction  \nIn recent years, prostate cancer has been ranked as one of the most diagnosed tumors in men. Androgens, testosterone, and 5α‐ dihydrotestosterone (DHT) play a pivotal role in the growth and maintenance of the prostatic cells. Many prostate cancers depend on the interaction between the androgen and its receptor (AR). In view of the former, androgen deprivation therapy (ADT) with steroidal or nonsteroidal antiandrogens has been the mainstay therapeutic option for the treatment of localized prostate cancer with a response rate higher than 80%. It has been reported that the nonsteroidal agents (such as flutamide and bicalutamide) are preferred over the steroidal antiandrogens (i.e., cyproterone acetate and mifepristone) as the latter induce adverse side effects owing to their interaction with the progestin and glucocorticoid receptors. In recent years, selective androgen receptor modulators (SARMs) have  \nbeen considered as the feasible future of androgen therapy as they can selectively target the AR in a tissue compared to the traditional antiandrogens. However, in many patients, it eventually progresses to castration‐resistant prostate cancer (CRPC), probably due to the emergence of mutations on the AR, with a worse prognosis, and has become a major clinical ongoing issue. Furthermore, the therapeutic potential of the AR antagonists currently marketed or undergoing clinical trials is hampered due to efficacy‐limiting side effects and drawbacks [1–3]. Thus, researchers are eager to find novel potent and safe therapeutic agents for both hormone‐ independent and ‐dependent prostate cancer cells. Currently, one of the practical approaches to these challenges is the direct manipulation of existing drugs to improve their therapeutic properties and efficacy. In this line, several modifications of the nonsteroidal antiandrogens (i.e., flutamide and bicalutamide) have been made [4–6]. Insertion of selenium (Se) functio","cbCaivdbhlHbd14U","https://ap.wps.com/l/cbCaivdbhlHbd14U","pdf",3482884,"English","# Introduction\n# Synthesis and biological evaluation","[{\"question\":\"What was developed in this study?\",\"answer\":\"The study developed sixteen novel Se-derivatives of flutamide designed to enhance activity against AR-dependent and AR-independent prostate cancer cells.\"},{\"question\":\"How did the Se-flutamide derivatives perform against cancer cell models?\",\"answer\":\"All Se derivatives showed promising activity across the NCI-60 panel, including AR-independent lines DU-145 and PC-3, while several compounds exhibited strong antiproliferative effects against AR-dependent LNCaP cells.\"},{\"question\":\"What mechanism of cell death did compound a5 trigger in LNCaP cells?\",\"answer\":\"Compound a5 promoted apoptosis by activating both intrinsic and extrinsic apoptotic pathways and did so without generating reactive oxygen species (ROS), also inducing G0/G1 cell cycle arrest.\"}]","Innovative Se-Flutamide Derivatives: Enhanced Activity Toward Androgen Receptor (AR)-Dependent and -Independent Prostate Cancer Cells | PDF",1790193159,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e92830126a0e9688adaac0dcfd8c2cbe.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5df5869ad08314ae410c3d0c4dbecb7f.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a971200761a9dbe316aa5545374884c5.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba2a51a99b4fb5fd20bc127822774e43.webp",980,1287]